Liang Ma

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Radiofrequency Ablation

Liver Metastases

Ejection Fraction

Top Venues

Journal of clinical and translational hepatology

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Le Li, Zhen-Zhen Li, Li-Xin Pan, Jia-Yong Su, Shan Huang, Liang Ma, Jian-Hong Zhong
Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions. Journal of clinical and translational hepatology 12 (5) (2024)
Le Li, Zhen-Zhen Li, Li-Xin Pan, Jia-Yong Su, Shan Huang, Liang Ma, Jian-Hong Zhong
Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions. Journal of clinical and translational hepatology 12 (5) (2024)
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of clinical and translational hepatology 10 (1) (2021)
Shao-Liang Zhu, Yuan-Qi Li, Hui Hu, Liang Ma
Letter: hepatocellular carcinoma surveillance determines survival in patients at risk. Alimentary pharmacology & therapeutics 50 (7) (2020)
Rong-Rui Huo, Jing-Rong Liang, Feng-Yi He, Bin-Rong Xu, Liang Ma, Wei-Ping Yuan
Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Alimentary pharmacology & therapeutics 50 (7) (2020)